| Literature DB >> 35276673 |
Jimmy J Caudell1, Maura L Gillison2, Ellie Maghami3, Sharon Spencer4, David G Pfister5, Douglas Adkins6, Andrew C Birkeland7, David M Brizel8, Paul M Busse9, Anthony J Cmelak10, A Dimitrios Colevas11, David W Eisele12, Thomas Galloway13, Jessica L Geiger14, Robert I Haddad15, Wesley L Hicks16, Ying J Hitchcock17, Antonio Jimeno18, Debra Leizman14, Loren K Mell19, Bharat B Mittal20, Harlan A Pinto11, James W Rocco21, Cristina P Rodriguez22, Panayiotis S Savvides23, David Schwartz24, Jatin P Shah5, David Sher25, Maie St John26, Randal S Weber2, Gregory Weinstein27, Frank Worden28, Justine Yang Bruce29, Sue S Yom30, Weining Zhen31, Jennifer L Burns32, Susan D Darlow32.
Abstract
The NCCN Guidelines for Head and Neck Cancers address tumors arising in the oral cavity (including mucosal lip), pharynx, larynx, and paranasal sinuses. Occult primary cancer, salivary gland cancer, and mucosal melanoma (MM) are also addressed. The specific site of disease, stage, and pathologic findings guide treatment (eg, the appropriate surgical procedure, radiation targets, dose and fractionation of radiation, indications for systemic therapy). The NCCN Head and Neck Cancers Panel meets at least annually to review comments from reviewers within their institutions, examine relevant new data from publications and abstracts, and reevaluate and update their recommendations. These NCCN Guidelines Insights summarize the panel's most recent recommendations regarding management of HPV-positive oropharynx cancer and ongoing research in this area.Entities:
Mesh：
Year: 2022 PMID： 35276673 DOI： 10.6004/jnccn.2022.0016
Source DB: PubMed Journal: J Natl Compr Canc Netw ISSN： 1540-1405 Impact factor: 11.908